Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women
HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »
